Annual D&A
$29.06M$252.00K+0.87%
Summary
- Current Value
- As of today, EXEL annual D&A is $29.06M, up +0.87% on
- Historical Performance
- EXEL annual D&A is up +39.19% over the past 3 years, up +107.97% over the past 5 years
- All-Time High Comparison
- EXEL annual D&A is currently at its all-time high
- 3-Year Low Comparison
- EXEL annual D&A is +39.19% above its 3-year low of $20.88M reached on an earlier date
- Sector Comparison
- EXEL annual D&A is higher than 81.11% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| $29.06M | +0.9% | +39.2% | +108.0% | +175.6% | ||
| $6.95M | -9.1% | +216.1% | +91.2% | +206.4% | ||
| $29.06M | +0.9% | +39.2% | +108.0% | +175.6% | ||
| Price | $43.42 | +17.2% | +123.7% | +87.8% | +278.6% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $1.54B | -6.7% | +7.6% | +75.6% | +454.3% | ||
| $1.34B | -4.2% | -0.6% | +59.7% | +2191.0% | ||
| Annual Revenue | $2.32B | +7.0% | +44.0% | +134.9% | +1153.8% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $29.06M | at high | |
| 5Y | $29.06M | at high | |
| All | $29.06M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $20.88M | N/A | +39.2% |
| 5Y | $13.97M | N/A | +108.0% |
| All | $731.00K | +3874.7% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of EXEL?
As of today, EXEL annual D&A is $29.06M
What is 1-year change in EXEL annual D&A?
EXEL annual D&A is up +0.87% year-over-year
What is 3-year change in EXEL annual D&A?
EXEL annual D&A is up +39.19% over the past 3 years
How far is EXEL annual D&A from its all-time high?
EXEL annual D&A is currently at its all-time high
How does EXEL annual D&A rank versus sector peers?
EXEL annual D&A is higher than 81.11% of companies in Healthcare sector
When is EXEL next annual earnings release?
As of today, the next annual earnings release for EXEL has not been scheduled
Quarterly D&A
$6.95M$476.00K-6.41%
Summary
- Current Value
- As of today, EXEL quarterly D&A is $6.95M, down -6.41% on
- Historical Performance
- EXEL quarterly D&A is down -9.11% year-over-year, up +216.06% over the past 3 years
- All-Time High Comparison
- EXEL quarterly D&A is currently -48.87% below its historical high of $13.59M set on
- 3-Year Low Comparison
- EXEL quarterly D&A is +190.40% above its 3-year low of -$7.68M reached on
- Sector Comparison
- EXEL quarterly D&A is higher than 79.08% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $6.95M | -6.4% | -9.1% | +216.1% | +91.2% | ||
| $29.06M | – | +0.9% | +39.2% | +108.0% | ||
| $29.06M | -2.3% | +0.9% | +39.2% | +108.0% | ||
| Price | $43.42 | -0.4% | +17.2% | +123.7% | +87.8% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $354.14M | -12.4% | -17.0% | -22.0% | +46.5% | ||
| $336.27M | +4.2% | -12.3% | -26.3% | +42.1% | ||
| Quarterly Revenue | $598.66M | +0.1% | +5.6% | +41.2% | +121.7% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.42M | -6.4% | |
| 3Y | $13.59M | N/A | -48.9% |
| 5Y | $13.59M | -48.9% | |
| All | $13.59M | -48.9% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.95M | at low | |
| 3Y | -$7.68M | +190.4% | |
| 5Y | -$7.68M | +190.4% | |
| All | -$7.68M | +190.4% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of EXEL?
As of today, EXEL quarterly D&A is $6.95M
What is EXEL quarterly D&A most recent change?
EXEL quarterly D&A was down -6.41% on December 1, 2025
What is 1-year change in EXEL quarterly D&A?
EXEL quarterly D&A is down -9.11% year-over-year
How far is EXEL quarterly D&A from its all-time high?
EXEL quarterly D&A is currently -48.87% below its historical high of $13.59M set on March 31, 2023
How does EXEL quarterly D&A rank versus sector peers?
EXEL quarterly D&A is higher than 79.08% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
TTM D&A
$29.06M$696.00K-2.34%
Summary
- Current Value
- As of today, EXEL TTM D&A is $29.06M, down -2.34% on
- Historical Performance
- EXEL TTM D&A is up +0.87% year-over-year, up +39.19% over the past 3 years
- All-Time High Comparison
- EXEL TTM D&A is currently -9.32% below its historical high of $32.04M set on
- 3-Year Low Comparison
- EXEL TTM D&A is +131.53% above its 3-year low of $12.55M reached on
- Sector Comparison
- EXEL TTM D&A is higher than 80.26% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $29.06M | -2.3% | +0.9% | +39.2% | +108.0% | ||
| $29.06M | – | +0.9% | +39.2% | +108.0% | ||
| $6.95M | -6.4% | -9.1% | +216.1% | +91.2% | ||
| Price | $43.42 | -0.4% | +17.2% | +123.7% | +87.8% | |
| -$565.72M | -206.7% | -214.9% | -223.0% | -292.9% | ||
| TTM Revenue | $2.32B | +1.4% | +7.0% | +44.0% | +134.9% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $29.78M | -2.4% | |
| 3Y | $32.04M | -9.3% | |
| 5Y | $32.04M | -9.3% | |
| All | $32.04M | -9.3% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $29.06M | at low | |
| 3Y | $12.55M | +131.5% | |
| 5Y | $12.55M | +131.5% | |
| All | $440.00K | +6503.4% |
TTM D&A History
FAQ
What is the current TTM D&A of EXEL?
As of today, EXEL TTM D&A is $29.06M
What is EXEL TTM D&A most recent change?
EXEL TTM D&A was down -2.34% on December 1, 2025
What is 1-year change in EXEL TTM D&A?
EXEL TTM D&A is up +0.87% year-over-year
How far is EXEL TTM D&A from its all-time high?
EXEL TTM D&A is currently -9.32% below its historical high of $32.04M set on June 30, 2023
How does EXEL TTM D&A rank versus sector peers?
EXEL TTM D&A is higher than 80.26% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
Data Sources & References
- EXEL Official Website www.exelixis.com
- EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
- EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel